GI Tolerance

Evaluating efficacy and consumer tolerance of fiber snack bars.

Objective

A Fortune 500 multinational packaged foods company sought to drive growth in a legacy fiber snack bar brand by launching new product line extensions with a re-formulated fiber ingredient.

Methodology

Development of a research plan to examine 4 test product iterations and identify the product with the greatest efficacy and likeability amongst consumers. The 100% virtual RCT collected data on clinical efficacy, GI tolerance, and consumer perceptions.

Results

New insights on GI response and product like-ability informed product development & marketing claims.

82,476

Data Points Evaluated in Real Time

90%

Data Points Evaluated in Real Time

Live Results

Data dashboards showed live results during the study.

"400 participants enrolled across US in 24-days at a fraction of the initial recruitment budget."

- Study Participant

Learn More About Our Remote Clinical Studies Platform

Are you interested in learning more about ObvioHealth’s proprietary platform built to withstand today’s challenges?

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.